Current Report Articles
FDA Critical Care Drug Monitoring

FDALogo (July 31, 2020) – The Food and Drug Administration recently reported that the generic drug supply for heparin sodium has been expanded, and heparin sodium has also been added to FDA List of Extended Use Dates. In addition, dexamethasone sodium phosphate has been added to FDA Temporary Policy for Compounding. FDA encourages continued voluntary submission of drug shortage information in the FDA-CDER COVID-19 critical care drug monitoring survey portal to assist with prioritizing the FDA’s work to address drug shortages.

--Karen Braman